We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Israeli generics major Teva has announced that it has settled its
legal dispute with UK drug major GlaxoSmithKline (GSK) over blockbuster central
nervous system drug Lamictal.
US-based drug firm Hana Biosciences has begun studies on a lingual
spray version for anti-emetic blockbuster ondansetron hydrochloride, marketed
by UK drug major GlaxoSmithKline as Zofran.
According to Chinese state media, leading Netherlands-based
vitamins producer Royal DSM NV has reached an initial agreement to acquire Shanghai
Pharmaceutical Group's 36% stake in its local vitamins joint venture.
Leading Israeli drugmaker Teva has announced that it has exercised
its option to enter into a joint venture with local stem-cell research firm
Gamida-Cell.
Local studies indicate that Brazilian generics sales have doubled
between 2001 and 2004, and now account for some 10 percent of total pharmaceuticals
sales, with market share reaching more than 20 percent in low-income areas.